Pepsinogen Test for the Evaluation of Precancerous Changes in Gastric Mucosa: a Population-Based Study (original) (raw)
Factors Associated with False Negative Results in Serum Pepsinogen Testing for Precancerous Gastric Lesions in a European Population in the GISTAR Study
Ilva Daugule
Diagnostics
View PDFchevron_right
Risk Assessment of Gastric Cancer and Precancerous Condition Using Serum Pepsinogen and H. Pylori Antibody Test
Erkhembulgan Purevdorj
Central Asian Journal of Medical Sciences
View PDFchevron_right
Serum pepsinogen test for early detection of gastric cancer in a European Country
Bento Bento
European Journal of Gastroenterology & Hepatology, 2012
View PDFchevron_right
Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions
Fariborz Mansour-ghanaei
2013
View PDFchevron_right
Are the Serum Biomarkers Pepsinogen I and II Good Predictors for the Detection of Subjects with Atrophic Gastritis in Areas that have Different Gastric Cancer Incidence?
arghavan sheykholeslami
Archives of Iranian medicine
View PDFchevron_right
Long-Term Results of Gastric Cancer Screening Using the Serum Pepsinogen Test Method Among an Asymptomatic Middle-Aged Japanese Population
Mitsuhiro Fujishiro
Digestive Endoscopy, 2009
View PDFchevron_right
Accuracy of pepsinogens for early diagnosis of atrophic gastritis and gastric cancer in Iranian population
Reza Taslimi
Medical journal of the Islamic Republic of Iran, 2014
View PDFchevron_right
Serum pepsinogen as a new marker for gastric carcinoma among young adults
Yutaka Inaba
Cancer, 1994
View PDFchevron_right
Serum Pepsinogen as a Predictor for Gastric Cancer Death: A 16-Year Community-based Cohort Study
Sherry Chiu
Journal of clinical gastroenterology, 2018
View PDFchevron_right
Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations
Gontar Siregar
PLOS ONE
View PDFchevron_right
Serum pepsinogen and Helicobacter pylori infection—a Japanese population study
Y. Urita
European Journal of Clinical Microbiology & Infectious Diseases, 2012
View PDFchevron_right
Cancer High-Risk Subjects Identified by Serum Pepsinogen Tests: Outcomes after 10-Year Follow-up in Asymptomatic Middle-Aged Males
Mitsuhiro Fujishiro
Cancer Epidemiology, Biomarkers & Prevention, 2008
View PDFchevron_right
Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests
Chisato Hamashima
BMC Cancer
View PDFchevron_right
Assessment of Serum Pepsinogens with and without Co-Testing with Gastrin-17 in Gastric Cancer Risk Assessment—Results from the GISTAR Pilot Study
Lilian Tzivian
Diagnostics
View PDFchevron_right
Usefulness of Serum Pepsinogen Levels as a Screening Test For Atrophic Gastritis and Gastric Cancer
F. Albayrak
eajm.org
View PDFchevron_right
The role of serum pepsinogen in the detection of gastric cancer
HYONG RYU
Gut and liver, 2010
View PDFchevron_right
Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study
Naomi Uemura
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016
View PDFchevron_right
Serum pepsinogen levels can quantify the risk of development of metachronous gastric cancer after endoscopic resection
Hideyuki Tamai
International journal of cancer, 2016
View PDFchevron_right
Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for …
joana barbosa
… (New York, NY), 2004
View PDFchevron_right
Screening of precancerous gastric lesions by serum pepsinogen, gastrin-17, anti-helicobacter pylori and anti- CagA antibodies in dyspeptic patients over 50 years old in Guilan Province, north of Iran
Fariborz Mansour-ghanaei
Asian Pacific journal of cancer prevention : APJCP, 2014
View PDFchevron_right
A 15-year cohort study on the incidence of gastric cancer and the validity of testing based on serum pepsinogen screening test
Koshi Nakamura
金沢大学つるま保健学会誌 Journal of the Tsuruma Health Science Society Kanazawa University, 2012
View PDFchevron_right
Serum Pepsinogen Levels, Helicobacter pylori CagA Status, and Cytokine Gene Polymorphisms Associated with Gastric Premalignant Lesions in Costa Rica
Ana Lucia Valerin
Cancer Epidemiology Biomarkers & Prevention, 2007
View PDFchevron_right
Validity of Serum Pepsinogen I/II Ratio for the Diagnosis of Gastric Epithelial Dysplasia and Intestinal Metaplasia during the Follow-Up of Patients at Risk for Intestinal-Type Gastric Adenocarcinoma
Rui Silva
Neoplasia, 2004
View PDFchevron_right
Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer
Renato Cannizzaro
Clinical and translational gastroenterology, 2016
View PDFchevron_right
Diagnosis of gastric adenocarcinoma using a scoring system: Combined assay of serological markers ofHelicobacter pylori infection, pepsinogen I and gastrin
Jawtown Lin
Journal of Gastroenterology, 1995
View PDFchevron_right